Learning Objectives

At the completion of the meeting, attendees should be able:

To understand genomics of Breast Cancer

To appreciate the potential role of biomarker prediction in making individual patient decisions

To adapt the latest clinical research in treatment of breast cancer for two important patient populations with Her 2 neu and Triple Negative disease

To review important endpoints in breast cancer research

To highlight emerging data presented at recent national and international breast cancer symposiums

To discuss the most promising future strategies for the management of breast cancer

To apply the existing data to daily decision making and management of patients with breast cancer